TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) Investor Securities Class Action Lawsuit 02/06/2018

  • If you purchased shares of Bellicum Pharmaceuticals Inc (NASDAQ: BLCM), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

May 29, 2020 - The court granted the defendants' motion to dismiss. July 5, 2019 - A motion to dismiss the amended complaint was filed. May 15, 2019 - An amended complaint was filed. February 6, 2018 - An investor in shares of Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) filed a lawsuit in the U.S. District Court for the Southern District of Texas over alleged violations of Federal...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: